INBRAIN harnesses the extraordinary material properties of Graphene, the world’s thinnest and nobel-prize winning material, to build safe, uninvasive and highly efficient neural solutions.
Parkinson’s disease example
Egnite™ is our patented Graphene innovation providing neurotechnological scalability
more sensitive neural signal readouts
channels in one interface
reduced power requirements thanks to higher charge injection limit & lower impedance
We are designing a comprehensive, AI, machine learning & data-driven neural platform that empowers patients, enables personalized care and provides accurate insights to support practitioners.
We develop high density and high resolution brain interfaces coupled to an intelligent system with high signal processing power to provide breakthrough neuroelectronic therapies (NETs)
Thanks to our expertise in cerebral signal decoding, we are developing with Merck KGaA innovative bioelectronics by selectively decoding and activating the vagus nerve targeting severe chronic diseases in Merck KGaA's therapeutic areas.
We are creating an intelligent data-hub to drive personalized neural digital therapeutics using real-time data processing with predictions and risk stratification tools to empower patients and physicians in their journey to health.
We hope to link the central and peripheral nervous system and ultimately help decoding and restoring a full range of neural related disorders
Masvidal et al., Nat.Mater. 2019
Garrido et al., Nat. Neurot. 2021
Kostarelos et al., Adv.Mat. 2017
“Elon Musk’s Neuralink is being outperformed by this Spanish graphene startup”.
“INBRAIN and Merck KgaA collaborate to develop the next generation of bioelectronic”
“INBRAIN, Neuralink, Kernel, Synchron, Blackrock, BrainQ make together a banner year for Neurotech”
Here are the latests news from INBRAIN